FDA-Drug2026-04-15Class IIPROCESSING DEFECT

Fresenius Kabi sodium chloride injection recalled for sterility assurance

OTHERNationwide distributionDrugs

What this means

Fresenius Kabi is recalling specific batches of 0.9% Sodium Chloride Injection due to a lack of assurance that the product is sterile. This injectable solution is used in medical settings and could pose a risk if contaminated. No injuries have been reported to date.

  • Check if you have Batch# 24LU10013, 24LU10014, 24NU10001, or 24NU10002 (expiring 09/30/2027 or 10/31/2027)
  • Do not use affected batches; quarantine them immediately
  • Contact your pharmacy, hospital, or healthcare provider if you have questions about whether your supply is affected
  • Report any use of recalled product to the FDA MedWatch program
The agency's original wording
Hazard

Lack of Assurance of Sterility

Intended for
All ages (under 100 years)
Illnesses reported
None reported
Sold states
US Nationwide , Alaska, and Puerto Rico.
Manufactured in
3 Corporate Dr, Lake Zurich, IL, United States
Products
0.9% Sodium Chloride Injection, USP, (4,500 mg per 500 mL) (9 mg per mL) 500 mL in a 500 mL freeflex bag, Rx only, Fresenius Kabi USA, LLC ("Fresenius Kabi"), Lake Zurich, IL 60047, Unit of Use NDC: 65219-472-05, Unit of Sale NDC Number: 65219-472-20.

Official notice

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0428-2026

More Fresenius Kabi recalls

Want us to check the next one for you?

We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.

Free · One email a week · Unsubscribe anytime